Overview

Argatroban Stroke Treatment - A Pilot Safety Study

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
Is the combination of low doses of argatroban in combination with rt-PA safe, and does it increase recanalization in patients with acute ischemic stroke.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Treatments:
Argatroban